SE464084B - Foerfarande foer framstaellning av 4-amino-1-hydroxi-butylidendifosfonsyra och 6-amino-1-hydroxihexylidendifosfonsyra - Google Patents
Foerfarande foer framstaellning av 4-amino-1-hydroxi-butylidendifosfonsyra och 6-amino-1-hydroxihexylidendifosfonsyraInfo
- Publication number
- SE464084B SE464084B SE8504687A SE8504687A SE464084B SE 464084 B SE464084 B SE 464084B SE 8504687 A SE8504687 A SE 8504687A SE 8504687 A SE8504687 A SE 8504687A SE 464084 B SE464084 B SE 464084B
- Authority
- SE
- Sweden
- Prior art keywords
- acid
- amino
- preparation
- ppm
- hydroxihexylideendifosphonic
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims 2
- 239000002253 acid Substances 0.000 title description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- PUUSSSIBPPTKTP-UHFFFAOYSA-N neridronic acid Chemical compound NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O PUUSSSIBPPTKTP-UHFFFAOYSA-N 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000003926 complexometric titration Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 4
- 125000004437 phosphorous atom Chemical group 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000003918 potentiometric titration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000003839 salts Chemical group 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- -1 phosphorus halide Chemical class 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- VGBPIHVLVSGJGR-UHFFFAOYSA-N thorium(4+);tetranitrate Chemical compound [Th+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VGBPIHVLVSGJGR-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23362/84A IT1196315B (it) | 1984-10-29 | 1984-10-29 | Procedimento per la preparazione di acidi difosfonici |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8504687D0 SE8504687D0 (sv) | 1985-10-09 |
| SE8504687L SE8504687L (sv) | 1986-04-30 |
| SE464084B true SE464084B (sv) | 1991-03-04 |
Family
ID=11206414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8504687A SE464084B (sv) | 1984-10-29 | 1985-10-09 | Foerfarande foer framstaellning av 4-amino-1-hydroxi-butylidendifosfonsyra och 6-amino-1-hydroxihexylidendifosfonsyra |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4705651A (nl) |
| JP (1) | JPS61109794A (nl) |
| AT (1) | AT391702B (nl) |
| BE (1) | BE903519A (nl) |
| CH (1) | CH663791A5 (nl) |
| DE (1) | DE3535404A1 (nl) |
| FR (1) | FR2572406B1 (nl) |
| GB (1) | GB2166741B (nl) |
| HK (1) | HK12891A (nl) |
| IT (1) | IT1196315B (nl) |
| LU (1) | LU86133A1 (nl) |
| NL (1) | NL193945C (nl) |
| SE (1) | SE464084B (nl) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3700772A1 (de) * | 1987-01-13 | 1988-07-21 | Inst Khim Kinetiki I Gorenija | Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen |
| GB8825589D0 (en) * | 1988-11-02 | 1988-12-07 | Albright & Wilson | Purification |
| US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
| US5019651A (en) * | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
| IT1246992B (it) * | 1991-01-08 | 1994-12-12 | Gentili Ist Spa | Procedimento per la preparazione di acidi difosfonici e loro sali |
| US5183815A (en) * | 1991-01-22 | 1993-02-02 | Merck & Co., Inc. | Bone acting agents |
| DE4223940A1 (de) * | 1992-07-21 | 1994-01-27 | Boehringer Mannheim Gmbh | Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| JPH0736804U (ja) * | 1993-12-25 | 1995-07-11 | 松本 純子 | 指圧クッションシート |
| US5773429A (en) * | 1996-12-11 | 1998-06-30 | Fuisz Technologies Ltd. | Drug combination for treating calcium loss |
| CA2197267C (en) * | 1997-02-11 | 2000-02-08 | Yong Tao | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
| DE69932620T2 (de) | 1998-08-27 | 2006-12-14 | Teva Pharmaceutical Industries Ltd. | Hydratformen des natriumsalzes von alendronat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten |
| US6331533B1 (en) | 1998-11-16 | 2001-12-18 | Merck & Co., Inc. | Method for inhibiting dental resorptive lesions |
| PL350126A1 (en) * | 1999-02-17 | 2002-11-04 | Teva Pharma | Novel process for preparing alendronic acid |
| US7205404B1 (en) | 1999-03-05 | 2007-04-17 | Metabasis Therapeutics, Inc. | Phosphorus-containing prodrugs |
| ES2153794B1 (es) | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
| PE20011065A1 (es) | 2000-02-01 | 2001-11-21 | Procter & Gamble | Proceso para fabricar bisfosfonatos geminales |
| US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| US6881420B2 (en) | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
| US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| US6558702B2 (en) * | 2001-04-13 | 2003-05-06 | Alkermes Controlled Therapeutics, Inc. | Method of modifying the release profile of sustained release compositions |
| US20060269602A1 (en) * | 2001-04-13 | 2006-11-30 | Dasch James R | Method of modifying the release profile of sustained release compositions |
| TR200101250A2 (tr) * | 2001-05-10 | 2003-04-21 | E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�. | 4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses |
| ES2336312T3 (es) | 2001-07-16 | 2010-04-12 | Universite Paris 13 | Procedimiento de preparacion de derivados de bisfosfonatos. |
| WO2003055496A1 (en) * | 2001-12-21 | 2003-07-10 | The Procter & Gamble Company | Method for the treatment of bone disorders |
| CA2481142C (en) | 2002-05-10 | 2012-11-13 | F.Hoffmann-La Roche Ag | Bisphosphonic acids for the treatment and prevention of osteoporosis |
| DE60331724D1 (de) * | 2002-05-17 | 2010-04-29 | Teva Pharma | Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren |
| US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
| JP4427453B2 (ja) | 2002-12-20 | 2010-03-10 | エフ．ホフマン−ラ ロシュ アーゲー | 高用量イバンドロネート製剤 |
| CN1325506C (zh) * | 2003-05-15 | 2007-07-11 | 中国科学院上海药物研究所 | 骨重吸收抑制剂阿伦膦酸及生理可接受的盐和它的制备 |
| ATE451380T1 (de) * | 2003-08-21 | 2009-12-15 | Sun Pharmaceuticals Ind Ltd | Verfahren zur herstellung von bisphosphonsäureverbindungen |
| US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
| US7361761B2 (en) * | 2004-09-28 | 2008-04-22 | Orchid Chemicals & Pharmaceuticals Ltd. | Process for the preparation of bisphosphonic acid |
| EP1832293A4 (en) * | 2004-12-10 | 2009-01-07 | Tmrc Co Ltd | MEANS FOR THE TREATMENT OF CANCER METASTAS AND CANNESMAS TREATMENT |
| CN1304401C (zh) * | 2004-12-28 | 2007-03-14 | 浙江工业大学 | 一种阿伦膦酸的制备方法 |
| EP1865967A4 (en) * | 2005-04-08 | 2011-02-09 | Chimerix Inc | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES |
| US8642577B2 (en) | 2005-04-08 | 2014-02-04 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
| US8003820B2 (en) * | 2005-10-20 | 2011-08-23 | Dr. Reddy's Laboratories Limited | Process for preparing bisphosphonic acids |
| PT1803727E (pt) * | 2005-12-27 | 2009-06-15 | Ipca Lab Ltd | Processo melhorado para o fabrico de ácido 4-amino-hidroxibutilideno-1,1 bisfosfónico e seus sais |
| WO2007083240A2 (en) | 2006-01-20 | 2007-07-26 | Aurobindo Pharma Limited | An improved process for the preparation of bisphosphonic acids |
| MX2010008148A (es) * | 2008-01-25 | 2010-10-20 | Chimerix Inc | Métodos de tratamiento de infecciones virales. |
| US7964584B2 (en) * | 2008-08-01 | 2011-06-21 | Dong Wha Pharmaceutical Co., Ltd. | Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
| TR200900880A2 (tr) | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik bileşimler. |
| US8614200B2 (en) | 2009-07-21 | 2013-12-24 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
| US20120164104A1 (en) | 2009-08-03 | 2012-06-28 | Chimerix, Inc. | Composition and Methods of Treating Viral Infections and Viral Induced Tumors |
| WO2011100698A2 (en) | 2010-02-12 | 2011-08-18 | Chimerix, Inc. | Methods of treating viral infection |
| CA2797601A1 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
| WO2012093974A1 (en) | 2011-01-06 | 2012-07-12 | Mahmut Bilgic | Improved bisphosphonate formulations |
| TR201100153A2 (tr) | 2011-01-06 | 2012-07-23 | Bi̇lgi̇ç Mahmut | Efervesan bifosfonat formülasyonları. |
| CA2937548C (en) | 2014-02-13 | 2022-10-25 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| JP2017520545A (ja) | 2014-07-02 | 2017-07-27 | リガンド・ファーマシューティカルズ・インコーポレイテッド | プロドラッグ化合物およびそれらの使用 |
| CN111788196A (zh) | 2018-01-09 | 2020-10-16 | 配体药物公司 | 缩醛化合物及其治疗用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4060546A (en) * | 1961-07-03 | 1977-11-29 | Henkel Kommanditgesellschaft Auf Aktien | Process for the manufacture of acylation products of phosphorous acid |
| US3366677A (en) * | 1965-05-13 | 1968-01-30 | Procter & Gamble | Low temperature preparation of ethane-1-hydroxy-1, 1-diphosphonic acid |
| DE2130794C3 (de) * | 1971-06-22 | 1974-07-11 | Joh. A. Benckiser Gmbh, 6700 Ludwigshafen | Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure |
| DE2534391C2 (de) * | 1975-08-01 | 1983-01-13 | Henkel KGaA, 4000 Düsseldorf | 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren |
| DE2702631A1 (de) * | 1977-01-22 | 1978-07-27 | Henkel Kgaa | Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren |
| DE2745083C2 (de) * | 1977-10-07 | 1985-05-02 | Henkel KGaA, 4000 Düsseldorf | Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung |
| DE2846835A1 (de) * | 1978-10-27 | 1980-05-08 | Benckiser Knapsack Gmbh | Verfahren zur herstellung von carboxylalkan-aminoalkan-diphosphonsaeuren und -aminoarylalkan-diphosphonsaeuren |
| SU783300A1 (ru) * | 1978-12-05 | 1980-11-30 | Предприятие П/Я А-7346 | Способ получени оксиэтилидендифосфоновой кислоты |
| DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
| GB2082585A (en) * | 1980-08-27 | 1982-03-10 | Vysoka Skola Chem Tech | 6-amino-1-hydroxyhexylidene diphosphonic acid, salts thereof and a method of producing the acid and salts. |
| US4304734A (en) * | 1980-10-16 | 1981-12-08 | Vysoka Skola Chemicko-Technologicka | 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof |
| DE3151038A1 (de) * | 1981-12-23 | 1983-07-28 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure |
-
1984
- 1984-10-29 IT IT23362/84A patent/IT1196315B/it active
-
1985
- 1985-10-01 CH CH4239/85A patent/CH663791A5/it not_active IP Right Cessation
- 1985-10-03 GB GB08524428A patent/GB2166741B/en not_active Expired
- 1985-10-03 DE DE19853535404 patent/DE3535404A1/de active Granted
- 1985-10-09 SE SE8504687A patent/SE464084B/sv not_active IP Right Cessation
- 1985-10-10 AT AT0292885A patent/AT391702B/de not_active IP Right Cessation
- 1985-10-11 US US06/786,815 patent/US4705651A/en not_active Expired - Lifetime
- 1985-10-11 FR FR858515062A patent/FR2572406B1/fr not_active Expired
- 1985-10-17 JP JP60232271A patent/JPS61109794A/ja active Granted
- 1985-10-23 LU LU86133A patent/LU86133A1/fr unknown
- 1985-10-25 BE BE2/60826A patent/BE903519A/nl not_active IP Right Cessation
- 1985-10-29 NL NL8502949A patent/NL193945C/nl not_active IP Right Cessation
-
1991
- 1991-02-28 HK HK128/91A patent/HK12891A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH663791A5 (it) | 1988-01-15 |
| NL193945C (nl) | 2001-03-02 |
| ATA292885A (de) | 1990-05-15 |
| GB2166741A (en) | 1986-05-14 |
| JPH0569110B2 (nl) | 1993-09-30 |
| JPS61109794A (ja) | 1986-05-28 |
| DE3535404C2 (nl) | 1989-04-20 |
| IT1196315B (it) | 1988-11-16 |
| DE3535404A1 (de) | 1986-04-30 |
| SE8504687D0 (sv) | 1985-10-09 |
| BE903519A (nl) | 1986-02-17 |
| FR2572406B1 (fr) | 1989-04-07 |
| IT8423362A1 (it) | 1986-04-29 |
| LU86133A1 (fr) | 1986-03-24 |
| GB2166741B (en) | 1988-07-20 |
| FR2572406A1 (fr) | 1986-05-02 |
| HK12891A (en) | 1991-03-08 |
| US4705651A (en) | 1987-11-10 |
| GB8524428D0 (en) | 1985-11-06 |
| IT8423362A0 (it) | 1984-10-29 |
| NL193945B (nl) | 2000-11-01 |
| NL8502949A (nl) | 1986-05-16 |
| AT391702B (de) | 1990-11-26 |
| SE8504687L (sv) | 1986-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE464084B (sv) | Foerfarande foer framstaellning av 4-amino-1-hydroxi-butylidendifosfonsyra och 6-amino-1-hydroxihexylidendifosfonsyra | |
| US4304734A (en) | 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof | |
| EP0724576B1 (en) | Non-alkaline purification of aminophosphonic acids | |
| SU850008A3 (ru) | Способ получени -замещенных -фос-фОНОМЕТилглициН- -ОКиСЕй | |
| SU843754A3 (ru) | Способ получени -(перфторацил) - -фосфонометилглицинов | |
| Failla et al. | Syntheses, characterization, stereochemistry and complexing properties of acyclic and macrocyclic compounds possessing α‐amino‐or α‐hydroxyphosphonate units: a review article | |
| Hariharan et al. | Synthesis of dipeptides of aminophosphonic acids | |
| GB1577795A (en) | N - phosphonomethylene - aminoalkane-phosphonic acids | |
| Browning et al. | Platinum (II) co-ordination chemistry of bis (diphenylphosphino) amine | |
| Brauer et al. | Chiral Phosphine Ligands from Amino Acids. II. A Facile Synthesis of Phosphinoserines by Nucleophilic Phosphination Reactions–X‐Ray Structure Analyses of Ar2P–CH2–CH (NHBOC)(COOMe)(Ar= Ph, m‐xylyl) | |
| Stenzel et al. | Iodine-Iodine Interactions in Dialkyldiiodophosphonium Iodides and Triiodides | |
| Stowell et al. | The mild preparation of synthetically useful phosphonic dichlorides: application to the synthesis of cyclic phosphonic diesters and diamides | |
| US3838124A (en) | Derivatives of isocyanuric acid and processes for preparing the same | |
| Burg | Reaction of bis (trifluoromethyl) phosphine with trimethylamine: new bis (phosphino) methanes, including an unusual triphosphine and a related tetraphosphine | |
| Failla et al. | SYNTHESIS AND CHARACTERIZATION OF AMINOPYRIDIN-2-YL-METHYL-PHOSPHONIC ACIDS | |
| McClarin et al. | Labilization of the 3-carbon hydrogens in chelated (2S)-aspartic acid and erythro-and threo-(2S)-3-methylaspartic acid | |
| JP3586872B2 (ja) | （メタ）アクリレート誘導体の製造方法 | |
| AU9543798A (en) | Novel methylenebisphosphonic acid derivatives | |
| Fei et al. | Synthesis of Symmetrical Bis‐(2‐chloro‐1, 3, 2‐benzodiazaphosphorinones) Hydrolysis and Fluorination of Selected Compounds | |
| US4473509A (en) | Process for making phosphonic anhydrides | |
| SU653264A1 (ru) | Способ получени неполных эфиров фосфорзамещенной метилфосфонистой кислоты | |
| SU1613130A1 (ru) | Способ получени кремнезема, модифицированного эфиром фосфоновой кислоты | |
| Fackler Jr et al. | Syntheses and characterizations of tin complexes of methylenediphenylphosphinate ligands: the crystal structures of [Ph4− xSn (CH2P (S) Ph2) x](x= 1–4) and [Ph2SnCl (CH2P (O) Ph2)] 2 | |
| SU507041A1 (ru) | Способ получени фосфорилированных имидатов | |
| PL219718B1 (pl) | Organiczna sól N-(salicylideno)-L-aminokwasu oraz sposób wytwarzania organicznej soli N-(salicylideno)-L-aminokwasu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8504687-8 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |